Evidence map›Paper›PMID 31264037›Full record

ReviewVirchows Archiv : an international journal of pathology2019

ACTH-producing tumorlets and carcinoids of the lung: clinico-pathologic study of 63 cases and review of the literature.

Stefano La Rosa, Marco Volante, Silvia Uccella, Roberta Maragliano, Ida Rapa, Nicola Rotolo, Frediano Inzani, Alessandra Siciliani, Pierluigi Granone, Guido Rindi and 5 more

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Virchows Archiv : an international journal of pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021
    Review
  13. Use ofFrontiers in oncology · 2021
    Article
  14. Morphologic and molecular classification of lung neuroendocrine neoplasms.Virchows Archiv : an international journal of pathology · 2021
    Review
  15. Article
  16. Neuroendocrine syndrome in bronchial carcinoid tumors.Experimental and therapeutic medicine · 2020
    Article
  17. Carcinoid Tumorlets Co-Existing with Chronic Pulmonary Inflammatory Processes: Imaging Findings and Histological Appearances.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Stefano La RosaInstitute of Pathology, University Hospital and University of Lausanne, Lausanne, Switzerland. stefano.larosa@chuv.ch.ORCID http://orcid.org/0000-0003-1941-2403
Marco VolanteDepartment of Oncology, University of Turin, San Luigi Hospital, Orbassano, Italy.
Silvia UccellaPathology Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Roberta MaraglianoPathology Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Ida RapaDepartment of Oncology, University of Turin, San Luigi Hospital, Orbassano, Italy.
Nicola RotoloCenter for Thoracic Surgery, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Frediano InzaniUOC Ginecopatologia e Patologia Mammaria, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Alessandra SicilianiUOC Chirurgia Toracica, Fondazione Policlinico Universitario A. Gemelli IRCCS-Università Cattolica del Sacro Cuore, Rome, Italy.
Pierluigi GranoneUOC Chirurgia Toracica, Fondazione Policlinico Universitario A. Gemelli IRCCS-Università Cattolica del Sacro Cuore, Rome, Italy.
Guido RindiUOC Anatomia Patologica, Fondazione Policlinico Universitario A. Gemelli IRCCS- Università Cattolica del Sacro Cuore, Rome, Italy.
Lorenzo DominioniCenter for Thoracic Surgery, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Carlo CapellaPathology Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Mauro PapottiDepartment of Oncology, City of Health and Science, University of Turin, Torino, Italy.
Fausto SessaPathology Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Andrea ImperatoriCenter for Thoracic Surgery, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
University of Insubria · ITUniversità Cattolica del Sacro Cuore · ITUniversity of Turin · ITAgostino Gemelli University Polyclinic · ITUniversity Hospital of Lausanne · CH

Funding

Associazione Italiana per la Ricerca sul Cancro IG 19238
6 · The paper itself

Abstract

Adrenocorticotropic hormone (ACTH)-secreting lung carcinoids represent the principal cause of ectopic Cushing syndrome, but the prevalence of ACTH expression and the association between ACTH production and Cushing syndrome in lung carcinoids have scarcely been investigated. In addition, available information on the prognostic meaning of ACTH production is controversial. The aims of this multicentric retrospective study, also including a review of the literature, were to describe the clinico-pathologic features of ACTH-producing lung carcinoids, to assess recurrence and specific survival rates, and to evaluate potential prognostic factors. To identify ACTH production in 254 unselected and radically resected lung carcinoids, we used a double approach including RT-PCR (mRNA encoding for pro-opiomelanocortin) and immunohistochemistry (antibodies against ACTH and β-endorphin). Sixty-three (24.8%) tumors produced ACTH and 11 of them (17.4%), representing 4.3% of the whole series, were associated with Cushing syndrome. The median follow-up time was 71 months. The 10-year overall and specific survival rates were 88.5% and 98.2%, respectively, with difference neither between functioning and nonfunctioning tumors nor between ACTH-positive and ACTH-negative carcinoids. At univariate analysis, histological type (typical or atypical) and Ki67 index significantly correlated with tumor recurrence. The literature review identified 172 previously reported patients with functioning ACTH-secreting lung carcinoids, and the meta-analysis of survival showed that 92% of them were alive after a mean follow-up time of 50 months. Our results demonstrate that ACTH-producing lung carcinoids are not rare, are not always associated with Cushing syndrome, and do not represent an aggressive variant of lung carcinoid.

Indexed as

Adrenocorticotropic HormoneAdultAgedCarcinoid TumorCushing SyndromeFemaleHumansLungLung NeoplasmsMaleMiddle AgedNeoplasm Recurrence, LocalPrognosisRetrospective StudiesSurvival RateAdrenocorticotropic HormoneACTHAdrenocorticotropic hormone-producing lung carcinoidCushing syndromeKi67 indexPrognostic factors

Identifiers

PMID31264037
OpenAlexW2953633385

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.